- By insider
Chairman, President & CEO of Merck & Co Inc (MRK) Kenneth C Frazier sold 140,000 shares of MRK on 11/10/2016 at an average price of $65.03 a share. The total sale was $9.1 million.
Merck & Co Inc is a health care company that delivers health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. Merck & Co Inc has a market cap of $163.87 billion; its shares were traded at around $64.96 with a P/E ratio of 33.31 and P/S ratio of 4.56. The dividend yield of Merck & Co Inc stocks is 2.83%. Merck & Co Inc had an annual average EBITDA growth of 4.70% over the past 10 years.
-
Warning! GuruFocus has detected 4 Warning Sign with MRK. Click here to check it out.
-
The intrinsic value of MRK
CEO Recent Trades:
-
Chairman, President & CEO Kenneth C Frazier sold 140,000 shares of MRK stock on 11/10/2016 at the average price of $65.03. The price of the stock has decreased by 0.11% since.
Directors and Officers Recent Trades:
-
EVP Strat Comm, Gl Pub Policy Julie L. Gerberding sold 85,523 shares of MRK stock on 11/07/2016 at the average price of $60.02. The price of the stock has increased by 8.23% since.
-
Director Rochelle B Lazarus sold 20,000 shares of MRK stock on 11/02/2016 at the average price of $59.06. The price of the stock has increased by 9.99% since.
-
Director Peter C Wendell sold 5,000 shares of MRK stock on 11/02/2016 at the average price of $59.5. The price of the stock has increased by 9.18% since.
For the complete insider trading history of MRK, click here
.This article first appeared on GuruFocus.
-
Warning! GuruFocus has detected 4 Warning Sign with MRK. Click here to check it out.
-
The intrinsic value of MRK